Sign Up to like & get
recommendations!
0
Published in 2018 at "PharmacoEconomics"
DOI: 10.1007/s40273-018-0658-x
Abstract: BackgroundRecently developed asthma biological therapies have been shown to provide relief for severe asthma patients not controlled by inhaled treatment. Given the relatively high costs of biological therapies, cost-effectiveness analyses (CEAs) may be required as…
read more here.
Keywords:
recommendations future;
cost effectiveness;
cost;
biological asthma ... See more keywords